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The development of autoimmune disorders is incompletely understood. Inefficient
thymic T cell selection against self-peptides presented by major histocompatibility
antigens (HLA in humans) may contribute to the emergence of auto-reactive effector
cells, and molecular mimicry between foreign and self-peptides could promote T
cell cross-reactivity. A pair of class I subtypes, HLA-B2705 and HLA-B2709, have
previously been intensely studied, because they are distinguished from each other
only by a single amino acid exchange at the floor of the peptide-binding groove, yet
are differentially associated with the autoinflammatory disorder ankylosing spondylitis.
Using X-ray crystallography in combination with ensemble refinement, we find that
the non-disease-associated subtype HLA-B2709, when presenting the self-peptide
pGR (RRRWHRWRL), exhibits elevated conformational dynamics, and the complex
can also be recognized by T cells. Both features are not observed in case of the
sequence-related self-peptide pVIPR (RRKWRRWHL) in complex with this subtype, and
T cell cross-reactivity between pGR, pVIPR, and the viral peptide pLMP2 (RRRWRRLTV)
is only rarely observed. The disease-associated subtype HLA-B2705, however, exhibits
extensive conformational flexibility in case of the three complexes, all of which are also
recognized by frequently occurring cross-reactive T cells. A comparison of the structural
and dynamic properties of the six HLA-B27 complexes, together with their individual
ability to interact with T cells, permits us to correlate the flexibility of HLA-B27 complexes
with effector cell reactivity. The results suggest the existence of an inverse relationship
between conformational plasticity of peptide-HLA-B27 complexes and the efficiency of
negative selection of self-reactive cells within the thymus.
Keywords: HLA-B27, X-ray structure, peptide binding modes, conformational flexibility, T cell selection, central
tolerance, molecular mimicry, ankylosing spondylitis
INTRODUCTION
Although the vast majority of autoimmune diseases is associated with HLA class II alleles (1),
the first association detected and still one of the strongest found so far is that between the
class I gene HLA-B∗27 and the autoinflammatory rheumatic disorder ankylosing spondylitis
(AS) (2, 3). Rats and mice transgenic for HLA-B∗27 demonstrate a direct involvement of
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the HLA-B27 protein in the development of diseases in the
animals that share many features with AS (4–8). In humans, not
all of the >170 alleles (“subtypes”) of HLA-B∗27 are associated
with AS: while the prototypical HLA-B∗27:05 subtype (B∗27:05
in short) is AS-associated, HLA-B∗27:09 (in short, B∗27:09) is
not (9). Both alleles encode a heavy chain (HC) that associates
non-covalently with a light chain, β2-microglobulin (β2m), and
a self- or foreign peptide. The B2705 and B2709 complexes
are distinguished only by an Asp116His exchange within their
HC, located on the floor of the peptide binding groove within
the F-pocket. Comparative studies of these two subtypes can
thus be regarded as promising to understand various aspects of
AS pathogenesis.
Functional, X-ray crystallographic, spectroscopic, and
calorimetric experiments as well as molecular dynamics
(MD) simulations have already shown that the Asp116His
micropolymorphism of the HC, combined with differential
peptide binding, leads to an overall structural polymorphism of
the subtypes that is responsible for several distinct features of
B2705 and B2709 [reviewed by (10–12)]. For example, cytotoxic
T lymphocytes (CTL) directed against the self-peptides pVIPR
[RRKWRRWHL, derived from vasoactive intestinal peptide
type 1 receptor (residues 400–408)] and pGR [RRRWHRWRL,
derived from glucagon receptor (residues 412–420)] have been
found in individuals with B∗27:05 (13, 14). About one sixth
of these T cells cross-reacts with the viral pLMP2 peptide
[RRRWRRLTV, derived from latent membrane protein 2
(residues 236–244)] of Epstein-Barr virus (EBV) (15), suggesting
the existence of B2705-restricted molecular mimicry between the
three peptides (14). In contrast, CTL cross-reactivity between
the pVIPR and pLMP2 peptides has only rarely been observed
when these ligands are displayed by B2709, suggesting lack of
molecular mimicry (16). X-ray crystallographic studies support
these conclusions (15) and indicate that structural similarity does
not only form the basis for the observed CTL cross-reactivity in
B∗27:05+ individuals, but argues also in favor of a relationship
with the pathogenesis of AS. Although crystallographic studies
had thus implicated structural features of complexes with the
pGR, pVIPR, and pLMP2 peptides displayed by B2705 as the
basis for CTL recognition and suggested a connection with
the initiation of AS, results from infrared (IR) spectroscopy
demonstrated that an increase in conformational flexibility
might in fact be more important than structural peculiarities in
explaining the association of certainHLA-B∗27 subtypes (besides
B∗27:05 also B∗27:04) with disease (17).
In the present work, we extend the structural analyses
of complexes with pGR and related peptides to the B2709
subtype, taking functional studies with CTL from B∗27:09+
individuals into account (16). We address three issues in
particular: (i) Is the extent of peptide dynamics a consequence
of display by a particular HLA-B27 subtype? (ii) Does the
overall conformational plasticity of a given peptide-HLA-B27
complex allow to correlate this property with CTL reactivity?
and (iii) Do the complexes of B2709 displaying pGR, pVIPR,
or pLMP2 exhibit a lack of comprehensive molecular mimicry?
Together with previously published studies (13–16, 18) the
high resolution structure of pGR-B2709 that we describe here
permits to shed light on these questions and indicates that the
occurrence of peripheral self-reactive CTL is connected with the
conformational plasticity of peptide-HLA-B27 complexes.
MATERIALS AND METHODS
Protein Preparation, Crystallization and
Data Collection
The peptide pGR (RRRWHRWRL) was purchased from Alta
Bioscience (Birmingham, UK). B2709 HC, and β2m were
expressed separately as inclusion bodies in Escherichia coli,
dissolved in 50% urea and pGR-B2709 complexes were
reconstituted using a protocol described previously (13, 19). The
complexes were isolated by size exclusion chromatography and
used for crystallization at concentrations of 13–15 mg/ml in
20mM Tris/HCl (pH 7.5), 150mM NaCl, 0.01% sodium azide.
Crystals were obtained from drops mixed of 1.5 µl protein and
1.5 µl precipitant solution [12–16% (w/v) polyethylene glycol
(PEG) 8000, 100mM Tris/HCl, pH 7.5 or 8.0] in a hanging-
drop vapor diffusion setup applying streak seeding techniques.
Synchrotron X-ray diffraction data to 1.12 Å resolution were
collected at European Synchrotron Radiation Facility (ESRF,
Grenoble, France) at beamline ID 14-2 from cryo-cooled
crystals with 10% (w/v) glycerol and 20% (w/v) PEG 8000 as
cryoprotectant at 100K. The data were processed and scaled
with the HKL package (20) (Table 1). The raw diffraction
images are made public through www.proteindiffraction.org
(doi: 10.18430/m33czf).
Structure Determination, Refinement, and
Analysis
The structure of pGR-B2709 was solved by molecular
replacement with the program EPMR (21) using water-
and peptide-depleted m9-B2709 structures as search model
(PDB entry 1K5N) (22). The crystallographic asymmetric unit
contains one pGR-B2709 complex with a Matthews coefficient
of 2.8 Å3 Da−1 corresponding to a solvent content of 55%
(23). For calculation of a free R-factor, a randomly generated
set of 2.5% of the reflections from the diffraction data set was
used and excluded from refinement. Restrained maximum-
likelihood refinement was performed using REFMAC5 (24)
including anisotropic B-factor refinement followed by iterative
manual model building with the program COOT (25). Water
molecules were positioned with ARP/wARP (26) and manually
inspected. For data collection and refinement statistics see
Table 1. Intermediate and final structures were evaluated with
MOLPROBITY (27) and PROCHECK (28). Figures were
prepared with PYMOL (29). The atomic coordinates and
structure amplitudes have been deposited in the Protein Data
Bank (PDB entry 3CZF).
Ensemble Refinement
The starting structures for ensemble refinements as implemented
in PHENIX (30) were prepared as described (18, 31). Apart
from pGR-B2709 (this study), the following complexes were
analyzed: pGR-B2705 [PDB entry 2A83 (14)], pVIPR-B2709
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Unit cell [a,b,c (Å); β (◦)] 51.0, 81.9, 65.4; 108.9
Resolution (Å)a 30.0–1.1 (1.12–1.10)
Unique reflectionsa 196,702 (9,285)




Wilson B factor (Å2) 14.7
Refinement
Resolution (Å) 15.0–1.20




Heavy chain, no. of atoms/average B factor (Å2) 2,439/12.5
β2m, no. of atoms/average B factor (Å2) 913/14.2
Peptide, no. of atoms/average B factor (Å2) 149/12.2
Water, no. of molecules/average B factor (Å2) 712/27.1
Glycerol, no. of atoms/average B factor (Å2) 30/23.4
rmsde from ideal geometry, bond length (Å) 0.011
bond angles (◦) 1.427
Ramachandran outliers (%) 0.3
Ramachandran favored (%) 98.1
aValues in parentheses refer to the highest resolution shell.
bRsym = ΣhΣi | Ih,I-<Ih >| / ΣhΣi Ih,i .
cRcryst = Σh | Fo-Fc | / Σ Fo (working set, no σ cut-off applied).
dRfree is the same as Rcryst, but calculated on 2.5% of the data excluded from refinement.
eRoot-mean-square deviation (rmsd) from target geometries.
(PDB entry 5IB5), pVIPR-B2705 [PDB entry 5IB2 (18)], pLMP2-
B2709 [PDB entry 1UXW (15)], and pLMP2-B2705 [PDB entry
1UXS (15)]. Briefly, alternate conformations of amino acid side
chains were removed from the deposited structures in the PDB
and the occupancies adjusted to 1. Prior to refinement, explicit
hydrogen atoms were generated with phenix.ready_set. The
ensemble refinements were executed with the standard settings.
For glycerol molecules, harmonic restraints were set to avoid
stochastic displacement during simulations.
RESULTS
Structural Characteristics of the
pGR-B2709 Complex
pGR-B2709 crystallized in space group P21 like B2705 bound
to pGR (14), or both subtypes in complex with the sequence-
related pVIPR (18) and pLMP2 peptides (15). The structure of
the pGR-B2709 complex exhibited very high resolution of 1.2
Å and was refined to R/Rfree of 0.129/0.149. For detailed X-ray
diffraction and refinement statistics see Table 1. As expected, the
FIGURE 1 | General structural properties of the bound pGR peptide displayed
by B2709. For sake of clarity, water molecules are omitted in all
representations. In (A–C), the view is from the side of the α2-helix, which is not
displayed. (A) Final 2Fo-Fc electron density maps (blue mesh) contoured at 1.3
σ, with pGR in A-conformation (cyan) and in B-conformation (orange) shown in
stick representation. The subtype-specific residue His116 of the HC is shown
as well. (B) Color scheme depicting the anisotropic B-factor distribution in
both pGR conformations. (C) Superimposition of both pGR conformations,
viewed as in (A). (D) Superimposition of both pGR conformations, 90◦ rotated
toward the viewer in comparison to (C).
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single polypeptide chains, HC and β2m, show the protein fold
characteristic for HLA class I molecules (32, 33). Differences to
other HLA-B27 complexes are restricted to polymorphic residues
such as Asp116His in the B2705/B2709 pair, to conformations
of solvent-exposed amino acid side-chains and peptide residues,
as well as to the location of water molecules. Notably, none of
the peptide residues in pGR-B2705 or pGR-B2709 is involved in
crystal contacts.
As the calculated electron density map is of excellent quality,
two conformations of the pGR Cα-backbone, designated A and
B, could readily be assigned, between the two arginine residues
at position 6 (p6) and p8 (Figure 1A), although the overall
difference exhibited by both peptide Cα-traces is minimal [root
mean square deviation (r.m.s.d.) of 0.2 Å]. From the electron
density, the ratio of conformations A to B was estimated to
be about 70–30%. The B-factors of the bound peptides in the
A and the B conformation are virtually identical (Figure 1B).
In addition to the difference between the Cα-backbones of
the peptide, double conformations are also observed for the
side chains of four peptide residues, pTrp4, pArg6, pTrp7, and
pArg8 (Figures 1C,D).
Comparative Structural Features of
pGR-HLA-B27 Complexes
When the nona-peptides are neglected, the structures of pGR-
B2709 and pGR-B2705 superimpose with an r.m.s.d. of 0.3
Å for the Cα-atoms and must thus be considered virtually
identical. Both pGR peptide conformations assume the “p6α”
binding mode (i.e., main-chain φ/ψ torsion angles in α-helical
conformation at p6) in the B2709 subtype. This unconventional
(non-canonical, NC) conformation had been detected so far in
case of B2705 in complex with the peptides pVIPR (18), pLMP2
(15), pGR (14), and in the pVIPR-U5-B2709 [modified pVIPR
with citrulline at p5 (34)] as well as in the pVIPR-B2706 (17)
complex. Whereas, easily distinguishable differences between the
Cα-conformations of pArg3 to pArg8 were observed in pGR-
B2705 (r.m.s.d. of 0.5 Å), the differences in pGR-B2709 are
very small and limited to the region from pArg6 to pArg8. A
comparison of the different conformations of the pGR peptide
in B2709 with those in B2705 reveals that they are slightly more
similar to pGR-B2705-B (r.m.s.d. for Cα positions of 0.2 Å) than
to pGR-B2705-A (r.m.s.d. for Cα positions of 0.4 Å).
As a consequence of the pGR peptide’s NC binding mode
in complex with B2709, the side chain of pHis5 points toward
the interior of the binding groove (Figures 1, 2A) and is
embedded in a dense network of hydrogen bonds which,
however, do not directly contact the subtype-specific His116
residue. pHis5 adopts a single conformation, in contrast to the
double conformation observed for this residue in pGR-B2705-
A and -B (Figures 2B,C) and the above-mentioned four other
peptide residues. In B2709, pHis5 engages in a direct contact
to the backbone carbonyl of pTrp7 and an indirect water-
mediated contact to pArg3NE as well as a further indirect
interaction to HC residue Asp77 which is located on the α1-helix
(Figure 2A). A detailed comparison with the contacts of pHis5 in
the B2705 subtype (Figures 2B,C) demonstrates that the pattern
FIGURE 2 | Contacts of the peptide residue pHis5. Peptide residues p3 to p9
and the HC residues Asp77 and His/Asp116 are shown in stick
representation, water molecules are drawn as red spheres, hydrogen bonds
are depicted as red dashed lines, and all distances are given in Å. The view is
through the α2-helix (removed), roughly along the length of the peptide binding
groove toward the N-terminal peptide residues. (A) pHis5 of pGR-B2709 in
A-conformation (cyan) is embedded in a dense hydrogen bonding network
resulting in direct and indirect contacts. (B) pHis5 of pGR-B2705 in
A-conformation (yellow) is involved in hydrogen bonding which includes several
contacts that are mediated by water molecules. (C) pHis5 of pGR-B2705 in
B-conformation (pink) is involved in fewer contacts compared to (A,B).
of interactions in B2709 is a “hybrid” between the contacts
exhibited by pHis5 in the two B2705 conformations. In B2709,
the contacts to Asp77 and to His116 are more similar to those
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found in pGR-B2705-A (Figure 2B), while the interaction with
pArg3 resembles that observed in pGR-B2705-B (Figure 2C).
Table 2 provides a detailed account of the contacts of the pGR
peptide in complex with B2705 and B2709. Of note, the van
der Waals contact between pTrp4 and the HC residue Ile66
is present in the complexes of both subtypes. In contrast, this
contact is restricted to B2705 presenting pVIPR or pLMP2 (13,
15, 18), suggesting that the NC peptide binding mode could be a
prerequisite for this interaction.
The “hybrid” nature of structural features within the pGR-
B2709 complex extends to properties of the side chains of peptide
residues that exhibit conformational dimorphism. A comparison
with the respective pGR-B2705-A and -B conformations
(Figure 3) shows that pTrp4, pArg6, and pArg8 of pGR-B2709-
A exhibit a nearly identical conformation to that found in
B2705. In contrast, pTrp7 of pGR-B2709-A is very similar to
the B conformation, which this residue adopts in pGR-B2705.
In case of the B conformation in B2709, pTrp4 is identically
and pArg6 similarly bound as in pGR-B2705-B. Conversely,
pTrp7 and pArg8 in pGR-B2709-B are nearly identical to the A
conformation, which is observed in B2705 (14).
Despite these differences, the results demonstrate that there
are several features which are shared by the two pGR-HLA-
B27 complexes. Irrespective of the subtype or the A or
B conformations, the pGR residues pArg1 and pArg2 are
identically anchored in the characteristic binding mode that has
been observed before (13–15, 34–36), pHis5 is always nearly
identically located, and the terminal pLeu9 is embedded within
the F-pocket as in case of the peptides pVIPR (13), TIS (36), and
pVIPR-U5 (34).
Structural Similarities and Differences
Between the pGR, pVIPR, and pLMP2
Peptides in Complex With HLA-B27
Subtypes
The isomorphous crystallization modes of the HLA-B27
complexes with the peptides pVIPR (18), pLMP2 (15), and
pGR [(14) and this study], permit a detailed comparison of
their structures. Previous work had already shown that the
structures of these three peptides are very similar, at least in
their N-terminal two thirds, when presented by the B2705
subtype, thereby furthering molecular mimicry (14). This is due
to the NC binding mode of the displayed peptide which is
exhibited by all of the complexes. In contrast, despite sharing the
canonical conformation (CC), pVIPR and pLMP2 are differently
presented by the B∗2709 subtype, primarily because the side
chains at p3 (Lys or Arg) and pArg6 point to distinct directions
(Figure 3E) (15).
The comparison of the newly determined pGR-B2709
structure with those of pVIPR and pLMP2 reveals that pGR is
presented by this subtype in a further distinct manner, which is
dictated by the presence of the NC conformation (Figures 1–3).
Despite the expected close similarity around the p1 and p2 as
well as around the p8 and p9 peptide residues, the three peptides
deviate considerably from p3 to p7 (Figure 3E). The most
divergent conformations are exhibited by pTrp4 and pArg6 and
the residue (either a tryptophan or a leucine) at p7 (Figure 3C).
On the basis of these results, the presence of molecular mimicry
between pGR, pVIPR, and pLMP2 when displayed by B2709
must be regarded as highly unlikely.
This conclusion is further supported by analyses of peptide
plasticity using ensemble refinements (18, 31, 37, 38). This
approach permits to gain information on dynamic properties
of a protein whose structure had been solved by X-ray
crystallography, by employing short, steered molecular dynamics
(MD) simulations during the refinement process. The results
(Figures 4, 5A,B) demonstrate that pArg2 and pLeu9 are
virtually immobile, as expected for residues anchoring the
pGR peptide within the binding groove. In contrast, not
only the residues exhibiting double conformations, but all
residues from pLys3 to pArg8 are characterized by extensive
conformational plasticity in the complexes of both HLA-B27
subtypes presenting this peptide. The graphic presentation of
ensemble-refined structures poses a problem not encountered
when B-factors (temperature or Debye-Waller factors) calculated
for conventionally refined structures (compare Figure 1B) are
depicted. Since ensemble refinement allows to visualize B-
factors independent from the atomic fluctuations that can be
represented by multiple structures within the ensemble, high
(low) B-factors do not necessarily reflect elevated (decreased)
plasticity of residues within a molecule. This is due to the
well-known fact that B-factors do not only report on atomic
fluctuations, but are also influenced by factors such as crystal
lattice defects, rigid body motions, occupancy levels, radiation
damage, or refinement artifacts (39, 40). Consequently, regions
with a greater conformational flexibility, as revealed by ensemble
refinement, could have lower B-factors, since the ensemble is
more precisely reflecting the electron density (41), as seen e.g.,
in the case of pArg3 in pLMP2-B2709 (Figure 4E) and pArg5
in pLMP2-B2705 (Figure 4F). On the other hand, in case of
pArg1 the conformational flexibility is restricted due to pi-
pi interactions with the side chains of Arg62 and Trp167 of
the heavy chain (Figures 4, 5), that are both solvent exposed.
The protein environment could thus reduce the number of
possible side chain conformations. In contrast, the anchoring
residue pArg2 displays lower B-factors (Figures 4, 5), since it
is not pointing toward the solvent but into the interior of the
protein and as described for pArg1, the number of side chain
conformations is limited due to interactions with residues of the
heavy chain.
As previously described by us in detail (18), the pVIPR peptide
is considerably more mobile in B2705 than in B2709. Only pArg5
shows a moderate degree of plasticity in B2709 (Figures 4, 5C).
In the case of the pLMP2 peptide, the difference between the
subtypes is not as pronounced as for pVIPR, but the peptide
is definitely more mobile in its middle (residues p3–p7) when
bound to B2705 (compare Figures 4, 5E,F).
With regard to molecular mimicry, the ensemble refinements
permit to conclude that the probability that a TCR would
encounter a similar collection of structures among the three
peptides is far greater in the B2705 subtype than in the case
of B2709. For example, when comparing pVIPR-B2709 and
pLMP2-B2709, only the area “above” pArg1, pTrp4, and pArg5
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TABLE 2 | Comparison of pGR conformations in the B2705 and B2709 subtypes.
pGR-B2705 conformations A and B pGR-B2709 conformations A and B
Peptide residue Contact residue Distance Interaction Peptide residue Contact residue Distance Interaction
p1 & p2 Contacts formed by Arg1 and Arg2 are very similar in both complexes; the side chain of Arg1 is solvent-exposed, whereas Arg2 is buried
p3 pArg3N Tyr99OH 3.09 HB pArg3N Tyr99OH 3.1 HB
pArg3 Tyr99, Leu156, Tyr159 3.6–4.0 vdW pArg3 Tyr99, Leu156, Tyr159 3.6–4.0 vdW
pArg3NH2(A) pHis5ND1(A) 2.9 HB pArg3NE pTrp4O 2.8 HB
p4 The side chain of this residue is solvent-exposed in all complexes
pTrp4 Gln65, Arg62, Ile66 3.6-4.0 vdW pTrp4 Gln65, Arg62, Ile66 3.6-4.0 vdW
p5 The side chain of this residue is buried in all complexes
pHis5ND1(A) pArg3NH2(A) 2.9 HB pHis5NE2 Lys70 3.5 HB
pHis5NE2(B) pTrp7O(B) 3.1 HB pHis5NE2 pTrp7O(A) 3.1 HB
pHis5O (B) pArg8NH2 (B) 3.5 HB pHis5NE2 pTrp7O(B) 3.7 HB
p6 The side chain of this residue is solvent-exposed in all complexes
pArg6O(A) pArg8NH1 (A) 2.8 HB pArg6O(B) pArg8NH1 (A) 2.8 HB
pArg6NH2 (B) Gln155OE1 2.8 HB pArg6O(B) pArg8NH1 (B) 2.8 HB
p7 pTrp7O(A) pHis5NE2 (A) 3.3 HB pTrp7 Val152, Trp147 3.6-4.0 vdW
pTrp7O(B) pHis5NE2 (B) 3.1 HB
pTrp7 Ala150, Val152 ∼3.6 vdW
p8 The side chain of this residue is solvent-exposed in all complexes
pArg8NE (A) Glu76OE1 3.0 SB Arg8NE (A) Glu76OE2 (A) 3.0 SB
pArg8NH2 (A) Thr73OG1 3.5 HB Arg8NE (B) Glu76OE2 (A) 2.5 SB
pArg8NH2 (B) Asp77OD2 3.4 SB Arg8O Trp147NE1 2.9 HB
pArg8NE (B) Asp77OD1 3.2 SB
pArg8O Trp147NE1 2.9 HB
p9 The side chain of this residue is buried in both complexes .
Distances are given in (Å). Only direct intra-peptide contacts and contacts between the peptides and HC residues [distance cut-off 3.5 Å; hydrogen bond (HB), salt bridge (SB)] are
included; solvent-mediated interactions are omitted, and van der Waals (vdW) contacts are not given explicitly. Double conformations of amino acid residues are indicated by (A) or (B).
might evoke a response by a cross-reactive CTL, and an extension
of this cross-reactivity to pGR-B2709 is difficult to imagine
(compare Figures 4, 5A,C,E). This is very different in the case of
the disease-associated subtype (compare Figures 4, 5B,D,F). The
ensemble of structures exhibited by peptides bound to B2705 that
is available for CTL recognition is much larger than in case of the
B2709 subtype.
Distinct Dynamic Properties of the Peptide
Binding Grooves of the B2705 and B2709
Subtypes
The fact that the conformational plasticity of the three
peptides depends on the HLA-B27 subtype by which they are
displayed, leads to the question how the hidden Asp116His
micropolymorphism in the F pocket can influence the flexibility
of peptide residues that may be separated by more than 20
Å as in the case of His116 and the guanidinium group of
pArg1 (compare e.g., Figures 4, 5C,D). Therefore, we analyzed
also the overall appearance of the binding grooves by ensemble
refinement. Figure 6 depicts the six complexes recognizable by a
TCR. It is immediately obvious that pVIPR-B2709 (Figure 6C)
exhibits a greatly diminished degree of mobility, both of
the peptide and of large parts of the binding groove. This
property is not exhibited by any of the other complexes. In
particular, the F pocket, which accommodates the polymorphic
residue 116 (His in B2709), the peptide’s C-terminus, and its
surroundings show very little flexibility. A comparison with
the other five complexes reveals that large parts of the α1-
helix and the loops “below” it (HC residues 13–18 and 86–
90, Figure 6) as well as the beginning of the α2-helix exhibit
very little dynamics. Only that section of the binding groove
accommodating the N-terminal third of pVIPR as well as
the loop comprising residues 106–108 show a limited degree
of flexibility. Consequently, the three B2709 complexes share
neither a pronounced structural nor a dynamic similarity,
in contrast to the three B2705 complexes (Figures 6B,D,F).
Although the ensemble refinements of the peptide-HLA-B27
complexes provide a fairly good idea of the differential dynamics
which characterizes each of the binding grooves, the results do
not give a hint for the reasons underlying F-pocket effects on
the flexibility of distant peptide residues (see the interaction
between the guanidinium moiety of pArg1 and Asp/His116
mentioned above).
DISCUSSION
Conformational plasticity is a prerequisite for the successful
interaction of MHC molecules with extra- and intracellular
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FIGURE 3 | Comparison of the binding modes of pGR and three other peptides to B2709 and B2705. The peptides are viewed from the side of the α2-helix
(removed). The representations resemble those in Figures 1A,C. (A) A-conformation of pGR-B2709 (cyan), (B) B-conformation of pGR-B2709 (orange), (C)
A-conformation of pGR-B2705 (gold), (D) B-conformation of pGR-B2705 (pink). (E) Schematic representation of peptide side chain orientations when presented by
B2709. The peptides are viewed from the N- to the C-terminus. The following ligands are shown: pGR (A- or B-conformation, both in NC binding mode), pVIPR (in CC
binding mode), pLMP2 (in CC conformation), and pVIPR-U5 (pArg5 replaced by citrulline) in NC binding mode. The orientations of the peptide side chains are
indicated and the primary sequence of the peptides is given. The right panel shows schematically the floor of the peptide binding groove indicated by “β-sheet” and
binding region for a TCR by “TCR”.
binding partners. Following the pioneering studies with peptide-
HLA-A2 complexes and TCR molecules (42–44), also HLA-B27
subtypes have been employed in experimental studies regarding
the influence of a micropolymorphism in the F-pocket on the
dynamics of the peptide as well as the HC (17, 45–48). These
studies proved, that HC dynamics is more pronounced in
B2705 than in B2709, irrespective of the bound peptide. The
Asp116His polymorphism is thus not only linked to AS, but
also to HC flexibility. MD simulations support these results and
further suggest that HC dynamics and the conformational
plasticity of natural peptide ligands influence each
other (45, 47, 49–52).
Although all MD simulations performed in the context
of these studies indicate a higher flexibility of the B2705
F-pocket, one could argue that they examine rather limited
time spans, “several orders of magnitude shorter than
more biologically relevant timescales,” as pointed out by
Buckle and Borg (53), indicating a need for additional
dynamics-directed experimental studies. The present results
are based on a complex of B2709 and the pGR peptide
solved at near-atomic resolution, allowing to investigate
the structure in unprecedented detail. They permit an
in-depth comparison with pGR-B2705 [solved at 1.50 Å
resolution; (14)], relying on conventional crystallographic
procedures (Figures 1–3 and Table 2), but also on the
application of ensemble refinement to obtain an estimate of the
conformational plasticity of the molecules under investigation
(18, 31, 37, 38, 53).
While the two complexes displaying pGR are characterized
by similar peptide dynamics (Figures 4, 5A,B), this property
is much less pronounced, though still relatively similar in
complexes with the viral pLMP2 peptide (Figures 4, 5E,F).
However, a different situation is evident in the case of the
pVIPR peptide: while peptide plasticity is nearly absent when
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FIGURE 4 | Results of the ensemble refinement performed for the structures of pGR, pVIPR, and pLMP2 bound to B2709 and B2705, respectively. For clarity, the HC
and β2m are not shown. The peptide and the polymorphic residue at HC position 116 are displayed in stick representation. Peptides are color-coded by decreasing
temperature factor from red to blue. In some structures, certain residues are partly “hidden” by others (e.g., pArg6 is “behind” pArg5 in the pLMP2-B2709 complex).
(A) pGR-B2709, (B) pGR-B2705, (C) pVIPR-B2709, (D) pVIPR-B2705, (E) pLMP2- B2709, and (F) pLMP2- B2705. In the case of the pGR complexes, the A- and
B-conformations of the peptide (always in NC binding mode) are depicted for each subtype, while the other peptides [including pVIPR (18)] are shown in a single
conformation (either CC, pVIPR and pLMP2 bound to B2709, or NC, pVIPR and pLMP2 displayed by B2705).
pVIPR binds to B2709 (Figures 4, 5C), the ligand exhibits
drastically enhanced mobility when bound to B2705 (Figures 4,
5D). This elevated plasticity does not depend on a dual peptide
conformation as originally described by us (13). pVIPR is in
fact normally displayed by B2705 in a single NC conformation,
since the dual binding mode is induced by a metal ion
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FIGURE 5 | View as in Figure 4, but rotated by 90◦. Peptides are oriented such as an approaching TCR would “see” them. They are color-coded by decreasing
temperature factor from red to blue. (A) pGR-B2709, (B) pGR-B2705, (C) pVIPR-B2709, (D) pVIPR-B2705, (E) pLMP2-B2709, and (F) pLMP2-B2705. In some
structures, certain residues are partly “hidden” by others (e.g., pArg2 is “behind” pTrp4 in the pGR-B2709 complex). For the conformations and binding modes of the
peptides, please refer to the legend of Figure 4.
bound to the peptide (18). In addition, ensemble refinement
analyses show that enhanced flexibility is not only observed
for peptides bound to the complexes, but characterizes also
the HC (Figure 6). This HC flexibility is exhibited by residues
belonging to the beginning of the α1- and the end of the
α2-helices and the HC loops “beneath” the binding groove
(Figure 6A). The pVIPR-B2709 complex, however, shows a
different picture: while the regions comprising residues 54–58
and 175–181 (at the “left” end of the binding groove, opposite to
each other), as well as 106–108 reveal conformational flexibility,
the “right” part of the binding groove, “above” the F-pocket
and within a distance of about 15 Å from His116, exhibits
a nearly complete lack of mobility (Figure 6C). These results
are in complete agreement with the IR spectroscopic studies of
Fabian et al. which demonstrated that the B2705 HC is more
flexible than that of B2709, irrespective of the bound peptide
(47). All data are listed in Table 3, together with experimental
results obtained previously with two further peptides, pVIPR-
U5 (a citrullinated version of pVIPR, RRKWURWHL, U =
citrulline) (34) and TIS (RRLPIFSRL), a proven self-peptide for
both B2709 and B2705 (36). Experiments with another pair of
differentially AS-associated subtypes, B2704 and B2706, show
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FIGURE 6 | View onto the peptide binding groove, comparable to Figure 5. In addition to the peptide in stick representation, the HC in coil representation is shown.
For clarity, the α3 domain of the HC and β2m are not displayed. Color-coding by decreasing temperature factor from red to blue and in addition the diameter of the
coil reflect the mobility: the larger the diameter, the higher the mobility. Numbers indicate the position of amino acids within the protein sequence of the HC.
(A) pGR-B2709, (B) pGR-B2705, (C) pVIPR-B2709, (D) pVIPR-B2705, (E) pLMP2-B2709, and (F) pLMP2-B2705.
also that conformational flexibility characterizes AS-associated
subtypes (17).
Collectively, the X-ray crystallographic and dynamic studies
suggest that (i) the occurrence of peripheral CTL against a
given peptide-HLA-B27 complex correlates with the presence of
an elevated degree of conformational plasticity of the peptide
binding groove; (ii) as a rule, this flexibility is connected with
AS-associated subtypes such as B2705 (46–48) and B2704 (17),
although exceptions do exist (compare pGR-B2709, Figures 4,
5, 6A and Table 3); (iii) Neither a double conformation nor
an NC binding mode of a peptide are obligatorily connected
with the occurrence of CTL and disease [Table 3; (16, 17)]. For
example, pVIPR-U5 is bound by B2709 in an NC conformation,
but the HC flexibility was found to be low, while the CC binding
mode of this peptide to B2705 did not change the elevated HC
plasticity (48).
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TABLE 3 | Comparison of structural and dynamic properties of HLA-B27 complexes with their CTL-reactivity.
Non AS-associated AS-associated
Peptide B2709 B2705
pGR Peptide conformation NC, double conformation Peptide conformation NC, double conformation
(14)
Peptide flexibility High (ER) Peptide flexibility High (ER)
HC flexibility High (ER) HC flexibility High (ER)
Presence of CTL Yes (16) Presence of CTL Yes (14)
pVIPR Peptide conformation CC (18) Peptide conformation NC (18)
Peptide flexibility Marginal [ER, NMR (18)] Peptide flexibility High [ER, NMR (18)]
HC flexibility Marginal {ER, low [IR (47)]} HC flexibility High [ER, IR (47)]
Presence of CTL No& (16, 54) Presence of CTL Yes (16, 54)
pLMP2 Peptide conformation CC (15) Peptide conformation NC (15)
Peptide flexibility High [ER (18)] Peptide flexibility High [ER (18)]
HC flexibility Intermediate {ER, low [IR (48)]} HC flexibility High [ER, IR (46)]
Presence of CTL* Yes (16, 54) Presence of CTL Yes (16, 54)
pVIPR-U5 Peptide conformation NC (34) Peptide conformation CC (34)
Peptide flexibility ND Peptide flexibility ND
HC flexibility Low [IR (48)] HC flexibility High [IR (48)]
Presence of CTL ND Presence of CTL ND
TIS Peptide conformation CC (36) Peptide conformation CC (36)
Peptide flexibility ND Peptide flexibility ND
HC flexibility Low [IR (46)] HC flexibility High [IR (46)]
Presence of CTL ND Presence of CTL ND
B2706 B2704
pVIPR Peptide conformation CC/NC double conformation (17) Peptide conformation CC (17)
Peptide flexibility ND Peptide flexibility ND
HC flexibility Low [IR (17)] HC flexibility High [IR (17)]
Presence of CTL ND Presence of CTL ND
&pLMP2/pVIPR-cross-reactive CTL are rarely found in B*27:09+ individuals.
*The presence of CTL against pLMP2 is a consequence of infection with EBV.
Structural and dynamic properties were determined by X-ray crystallography with ensemble refinement (ER), NMR, and infrared (IR) spectroscopy. CTL-reactivity is attributed to a given
complex in individuals with the respective HLA-B*27 subtype (ND, not determined).
The results presented in Table 3 imply that the Asp116His
polymorphism within the F pocket is not only closely linked
to the presence (B∗27:05) or absence (B∗27:09) of AS and
other HLA-B∗27-associated autoinflammatory diseases, but is
also involved in determining the fate of self-reactive T cells in
the thymus. Together with previously obtained functional data
(16), our results establish a link between the flexibility of HLA
class I complexes and the occurrence of CTL directed against
self-peptidesat least in the two HLA-B27 subtypes investigated
here: the efficiency of negative T cell selection within the thymic
medulla is impaired when T cells encounter a highly flexible
binding groove, such as found for pGR-B2709, pGR-B2705, and
pVIPR-B2705 (Figures 6A,B,D and Table 3), and when peptide
dynamics is elevated beyond a certain level. This level is currently
ill-defined, but visual inspection as well as a comparison of
the number of conformations observed for the side chain of a
particular residue within an ensemble allow to conclude that a
single flexible peptide residue (pArg5 in pVIPR-B2709, Figures 4,
5C) does not prevent efficient T cell selection. Plasticity of further
positions, as in pVIPR-B2705 (Figures 4, 5D), on the other hand,
leads to failure of negative selection against this ligand. Therefore,
our results indicate the existence of a reciprocal relationship
between the efficiency of negative selection within the thymus
(55–57) and the extent of conformational plasticity of peptide-
HLA-B27 complexes.
If this scenario is correct, why are the surviving CTL
able to recognize their target outside of the thymus? Several
explanations can be thought of Yin et al. (58), e.g., by assuming
that different concentrations of the peptide in distinct tissues
could influence presentation or recognition. Another hypothesis
takes modifications of the target peptide into account, such as
citrullination, which can alter the binding mode to HLA-B27
subtypes (pVIPR-U5 as opposed to pVIPR) and which is known
to influence CTL recognition (34). Whether regulatory T cells
that have escaped negative thymic selection (59) play also a role
in initiating or propagating AS, must currently be regarded as a
matter of speculation.
A final question which we attempted to address is to explain
the abundance of cross-reactive CTL against displayed pGR,
pVIPR, or pLMP2 in B∗27:05+ individuals and the scarcity of
such CTL in B∗27:09+ individuals (16). Molecular mimicry has
been proven to exist in the HLA-B27 as well as other contexts (60,
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61) and may contribute also to the emergence of cross-reactive
CTL in certain subtypes. It remains still unknown whether
these cells do really play a decisive role in the development
of HLA-B∗27-associated diseases (62). We have already pointed
out that comprehensive molecular mimicry is a hallmark of
presentation by B2705 (14), and we show now that there is
neither a structural nor a dynamic basis for molecular mimicry
when the B2709 subtype displays the peptides pGR, pVIPR, and
pLMP2 (Figures 4–6).
The primary aim of our contribution was to investigate the
relationship of peptide- and binding groove-plasticity of HLA-
B27 subtypes to the efficiency of negative T cell selection. Due
to their distinct, peptide-independent conformational flexibility
(17, 46–48), however, peptide-devoid HC/β2m complexes within
a cell possess already the potential to differentially influence
peptide-loading processes (63–67). This could be relevant for the
subtype-dependent initiation of HLA-B∗27-associated diseases.
A deeper insight into the dynamics of these molecules is thus
crucial for a more detailed understanding of their function and
interaction with other proteins as well as their involvement in AS
and other disorders (53).
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